Delcath Systems, a small-cap healthcare equipment company, is expected to announce strong Q3 results on November 9, with a high chance of beating revenue estimates. The company’s recent success in the CHOPIN phase II trial and expansion of treatment centers support an anticipated 24% medium-term revenue growth. Despite a possible slight dip in gross margins this quarter, a rebound is expected in Q4. Risks include ongoing unprofitability through 2027 and increasing client concentration, but the stock remains attractively valued at a forward EV/sales of 3x and is trading above its 200-day moving average.
Delcath Systems is a small-cap healthcare equipment company anticipated to report strong Q3 earnings soon. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 09:12 WIB: Among 150 priced US health stocks, 86 rose and 60 fell today. Notable movers include WGS at USD 68.51 (+6.90%), TNGX at USD 23.17 (+6.48%), and AHCO at USD 6.28 (+6.26%), with varied Pluang order activity and typical hold times ranging from 4 to 21 days.
Milestone Pharmaceuticals announced the grant of 33,000 stock options to a newly hired employee as an inducement under Nasdaq Listing Rule 5635(c)(4). The options, priced at $0.72 each, will vest over four years with a one-year cliff and monthly inst...
The xZEC token has been launched on the Solana blockchain through the Hylo platform, marking its entry into a new network for digital assets and applications. Hylo, known for developing leveraged tokens and the decentralized stablecoin hyUSD on Solan...
Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...
Source Capital (SOR) has delivered an 8.1% total return over the past year with a low 5.8% volatility, outperforming standard 60/40 ETFs. The fund maintains a conservative portfolio with 16% cash and 48% equities, focusing on risk management and defe...
An attacker exploited a flash loan to manipulate CoreVault's price oracle on BNB Smart Chain, allowing them to redeem 33 times the value they should have, draining 160.26 BNB (about $112,200) from the protocol's InsurancePool. This pool is meant to c...
